Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 280 (RN7SKP280) is classified as a pseudogene and not a functional target in the context of receptors, enzymes, or other drug-targetable macromolecules[3]. It is an unprocessed or processed copy derived from the functional noncoding RNA gene RN7SK (RNA, 7SK small nuclear), but it lacks evidence of functional transcription and is generally considered non-functional as a protein or regulatory molecule[3][5]. The canonical, functional version of this molecule is "RN7SK," which encodes the 7SK small nuclear RNA—a central scaffold of the 7SK small nuclear ribonucleoprotein complex with important roles in transcriptional regulation and cell cycle control[1][2][6][7]. Pseudogenes such as RN7SKP280 typically do not have known therapeutic or biomarker roles, biological functions, or drug interactions because they do not produce an active molecule[5]. Note: - There is nothing in the available literature to suggest that RN7SKP280 is an accepted therapeutic target or has any validated biological function; it is a pseudogene, likely untranscribed or non-functional in disease or therapy[3][5]. - If your intent was to refer to the functional 7SK small nuclear RNA, the correct canonical target name would be "RNA, 7SK small nuclear" (abbreviation "RN7SK"); otherwise, RN7SKP280 is not appropriate for target analysis[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 280 (RN7SKP280).